|
Post by peppy on Jul 7, 2015 20:15:19 GMT -5
Here is a thought: Physicians are just now getting to see how (well) Afrezza is working for patients and they are starting to talk about it.
Patients talking about how much they like Afrezza. They feel better. (On twitter, and this board. Media spots.)
A drug that works well (GCOMs showing this) and the patients like. A drug that works well and patients like. Attachment Deleted57 plus years Type 1 diabetic [age 12 --- now 69] thousands and thousands of shots --- became needle-phobic A1C at start of inhaled insulin trial: 9.3% Now 6.8% Height: 5'3" Weight: 110 pounds Exercise: 5 - 6 days a week "To me, Afrezza is a miracle drug. I believe all Type 1 diabetics should give it a try." Attachment Deleted My endocrinologist, Dr. Denis L. Becker, Raleigh, NC is pro-Afrezza. He has received many national awards and I'm lucky he's my doctor.
He gave me permission to use his name and to quote him after working with Afrezza patients since March.
He is a believer due to the patient's positive response to Afrezza that he has obviously seen first hand.
My blood glucose numbers were also shared with his colleagues.
Doctor Becker is the founder of a practice that sees about 6,000 patients on average every month.
www.raleighendocrine.com/ourproviders.html
Thought I would pass this good news along.
_
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 8, 2015 7:28:36 GMT -5
Yeah, that last line is a bit sobering! Or Death knell? Not real reassuring of where SNY stands on this. I really wish I didn't read that pretty sure that came from the author editorializing for sensationalism purposes and not from MNKD or SNY I wish I could really believe that.
|
|
|
Post by bioexec25 on Jul 8, 2015 7:42:47 GMT -5
Believe itt Esstan!! Clearly the OR clause added at the end was the author's not Mnkd. It's done all the time and often intentionally creates ambiguity. Let's move on, we have enough to watch without manufacturing our own FUD.
|
|
|
Post by esstan2001 on Jul 8, 2015 7:57:18 GMT -5
Believe itt Esstan!! Clearly the OR clause added at the end was the author's not Mnkd. It's done all the time and often intentionally creates ambiguity. Let's move on, we have enough to watch without manufacturing our own FUD. Oh, I do believe it- makes NO sense for either MNKD or SNY to say such a thing, and all the sense in the world for a journalist / analyst that wants an increased following. Now talk to Avogadro; he's the one who posted with the doubts.
|
|
|
Post by bioexec25 on Jul 8, 2015 8:09:04 GMT -5
Apologies Esstan. Must be my early morning eyesight.
Meant to address Avo's comment. :-))
|
|
|
Post by esstan2001 on Jul 8, 2015 8:21:43 GMT -5
No problemo.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 8, 2015 8:26:32 GMT -5
Believe itt Esstan!! Clearly the OR clause added at the end was the author's not Mnkd. It's done all the time and often intentionally creates ambiguity. Let's move on, we have enough to watch without manufacturing our own FUD. Oh, I do believe it- makes NO sense for either MNKD or SNY to say such a thing, and all the sense in the world for a journalist / analyst that wants an increased following. Now talk to Avogadro; he's the one who posted with the doubts. OK, I admit it would be a bit extreme to expect that comment from MNKD or SNY, but the less than stellar market response to almost anything uttered by Matt, Ekam (sp?) or by SNY has me a little gunshy. I still experience a distinct bellyache when any of them speaks publicaly about Afrezza.
|
|
|
Post by esstan2001 on Jul 8, 2015 9:09:40 GMT -5
... but the less than stellar market response to almost anything uttered by Matt, Ekam (sp?) or by SNY has me a little gunshy. I still experience a distinct bellyache when any of them speaks publicaly about Afrezza. Granted they are not the most eloquent communicators; although their polish and sheen are improving as time marches on. With the throngs of shorts at the ready to bid the shares down, it will now take real material events to drive anticipation of higher scripts. Sanofi is in the process of putting those 'event' pegs in place- DTC, PCP / Endo education, removal of prior authorization; insurance tier movement to a better level...IMO factoring in the script lag, we'll start to see a response in scripts ~ 10 weeks from the ramp of this effort (end June), and they will build as each barrier gets lowered. A change in the rate of script movement will firm up and elevate our share price floor. Then longer term, looking forward to label improvement and pediatric trials that should commence late 15 / early 16 I look to mid 2016 for some real material action in the share price. In the interim, the shorts will continue to probe and play, trying to gauge their next moves. I know you have been worn down by this thing over many years (from your handle on yahoo) as have I. Look past the battle fatigue; We're in a much better place now, with the other side getting nervous after seeing the ammo & weapons deliveries we're taking in. :-)
|
|